| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |